Nipro Corporation TSE:8086

Nipro : Notice of International Sales Launch of DIAMAX™ WOW Single Patient Dialysis Machines

Published

Source: MarketScreener

January 23, 2025

NIPRO CORPORATION

Notice of International Sales Launch of

DIAMAX™ WOW Single Patient Dialysis Machines

NIPRO CORPORATION (Head Office: Settsu, Osaka; President: Yoshihiko Sano) is pleased to announce that sales of its DIAMAX™ WOW single patient dialysis machines for overseas began on January 17, 2025.

This single patient dialysis machine is now available to purchase across the globe, including Latin America and Asia. To better meet the diversifying needs of treatment sites, the DIAMAX™ WOW features improved basic performance, ease of use, and safety compared with conventional DIAMAX™ dialysis machines, including offering a variety of new functions.

As the number of dialysis patients continues to increase across the globe, NIPRO will begin delivering this product to medical treatment front lines around the world, helping to contribute to society by improving the quality of life for as many dialysis patients as possible and by reducing the burden on healthcare professionals.

Single Patient Dialysis Machine

  • Large 15-inch touch panel for easy viewability even from a distance
  • Intuitive and simple operation thanks to icons and graphic guidance
  • Enhanced checking functions for improved safety
  • Improved operability and slimmer size with a front-mountedB powder cartridge holder
  • Reduced pre-treatment time and improved efficiency with a liquid preparation time of less than 3 minutes, a thermal disinfection time of less than 30 minutes, and various automated functions
  • Minimal running costs throughout the product life cycle with an Eco-modefunction and highly durable solenoid valves

The NIPRO Group will continue to develop and provide products that keep users' viewpoints in mind while helping to contribute to the medical treatment front line.

This news release is meant to provide information on NIPRO's corporate activities and an overview of our initiatives to not only the press but also our many stakeholders, including shareholders and investors in a fair and timely manner. The information about NIPRO products and services included in this release is not intended for use in attracting customers or as medical advice.